Scott Johnson is a serial entrepreneur who is shaking up the pharma industry. Scott is the founder of the Myelin Repair Foundation, a non-profit patient funded foundation, which has put forth a new model to develop drugs for MS. In this interview, Scott describes this new approach and tells of his personal journey into drug development. Scott has MS.
